Cargando…
Country-specific regulation and international standardization of cell-based therapeutic products derived from pluripotent stem cells
Currently, many types of cell-based therapeutic products (CTPs) derived from pluripotent stem cells (PSCs) are being developed in a lot of countries, some of which are in clinical trial stages. CTPs are classified differently in different countries and regions. The evaluation of their efficacy, safe...
Autores principales: | Hirai, Takamasa, Yasuda, Satoshi, Umezawa, Akihiro, Sato, Yoji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10444560/ https://www.ncbi.nlm.nih.gov/pubmed/37557074 http://dx.doi.org/10.1016/j.stemcr.2023.05.003 |
Ejemplares similares
-
A selective cytotoxic adenovirus vector for concentration of pluripotent stem cells in human pluripotent stem cell-derived neural progenitor cells
por: Hirai, Takamasa, et al.
Publicado: (2021) -
A Novel In Vitro Method for Detecting Undifferentiated Human Pluripotent Stem Cells as Impurities in Cell Therapy Products Using a Highly Efficient Culture System
por: Tano, Keiko, et al.
Publicado: (2014) -
A study on ensuring the quality and safety of pharmaceuticals and medical devices derived from processing of autologous human induced pluripotent stem(-like) cells()
por: Hayakawa, Takao, et al.
Publicado: (2015) -
A study on ensuring the quality and safety of pharmaceuticals and medical devices derived from processing of allogeneic human induced pluripotent stem(-Like) cells()
por: Hayakawa, Takao, et al.
Publicado: (2015) -
Development of selective cytotoxic viral vectors for concentration of undifferentiated cells in cardiomyocytes derived from human induced pluripotent stem cells
por: Kono, Ken, et al.
Publicado: (2019)